Cochrane at crossroads over drug company sponsorship

Influence of drug company authorship and sponsorship on drug trial outcomes.

Studies of drug treatments are more likely to report favourable outcomes when they are funded by the pharmaceutical industry. We compared drug trials reported in three major psychiatric journals to investigate these influences. Independent studies were more likely to report negative findings than industry-funded studies. However, the involvement of a drug company employee had a much greater eff...

Pharmaceutical Company Sponsorship of Research: A Review

Many studies have shown that pharmaceutical companies' funding of clinical trials is associated with pro-industry results. This article reviews the literature on that association, confirming its existence, and discusses its causes and potential responses. The mechanisms of industry influence are varied, more than is usually acknowledged. It is straightforward to identify a number of distinct ki...

Cochrane in CORR ®: Industry Sponsorship and Research Outcome.

I n the past decade, the number of clinical trials funded by industry has substantially increased in the United States [9]. The drug and device industry now funds six times more clinical trials than the federal government [3]. This may be cause for concern, as publication agreements in which industry sponsors constrain academic authors’ independence are common [5] and several research articles ...

Motor racing, tobacco company sponsorship, barcodes and alibi marketing

BACKGROUND Sponsorship of Formula One (F1) motor racing, which has been used as an indirect medium of tobacco advertising for several decades, was prohibited by the 2005 European Union Tobacco Advertising Directive. Most F1 tobacco sponsorship of motor racing in the EU has since ceased, with the exception of the Scuderia Ferrari team, which continues to be funded by Philip Morris. In 2007, the ...

Editorial. At the crossroads.